Literature DB >> 2263221

Hormone replacement therapy: use patterns in 51-year-old Danish women.

A Køster1.   

Abstract

A survey based on a postal questionnaire sent to all women born in 1936 living in four Copenhagen suburbs (n = 597, response rate = 88%) revealed an overall prevalence of hormone replacement therapy (HRT) use of 22% and a cumulative incidence of 37%. This paper describes the use of HRT in this population and the patterns of exposure to treatment. Our results indicate that the use of HRT, particularly combined oestrogen-progestogen therapy, is increasing and is being initiated during the pre-menopause. Climacteric complaints were the main reason for starting treatment; only a minority of the respondents were motivated by prophylactic considerations. Forty percent discontinued treatment, the majority stating that they had done so because of unpleasant adverse reactions or lack of effect.

Entities:  

Mesh:

Year:  1990        PMID: 2263221     DOI: 10.1016/0378-5122(90)90014-w

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  10 in total

1.  Low use of long-term hormone replacement therapy in Denmark.

Authors:  C Olesen; F H Steffensen; H T Sørensen; G L Nielsen; J Olsen; U Bergman
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

2.  Performance of four clinical screening tools to select peri- and early postmenopausal women for dual X-ray absorptiometry.

Authors:  B Rud; J E B Jensen; L Mosekilde; S P Nielsen; J Hilden; B Abrahamsen
Journal:  Osteoporos Int       Date:  2004-09-30       Impact factor: 4.507

3.  Factors determining the use of hormone replacement therapy in recent naturally postmenopausal women participating in the French SU.VI.MAX cohort.

Authors:  S Mohammed-Cherif; S Briançon; G Potier de Courcy; P Preziosi; B Fieux; M Zarebska; P Galan; S Hercberg
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

4.  Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990-1995.

Authors:  M T Connelly; M Richardson; R Platt
Journal:  J Gen Intern Med       Date:  2000-08       Impact factor: 5.128

Review 5.  Hot flashes: aetiology and management.

Authors:  D Barton; C Loprinzi; D Wahner-Roedler
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

6.  Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark.

Authors:  Peter Vestergaard; Lars Rejnmark; Leif Mosekilde
Journal:  Osteoporos Int       Date:  2004-06-12       Impact factor: 4.507

7.  Determinants of hormone replacement therapy among postmenopausal women enrolled in the French GAZEL cohort.

Authors:  V Ringa; B Ledésert; G Bréart
Journal:  Osteoporos Int       Date:  1994-01       Impact factor: 4.507

8.  Levetiracetam for the treatment of hot flashes: a phase II study.

Authors:  Susan Thompson; Aditya Bardia; Angelina Tan; Debra L Barton; Lisa Kottschade; Jeff A Sloan; Brad Christensen; DeAnne Smith; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2007-06-28       Impact factor: 3.603

9.  Women with climacteric symptoms: a target group for prevention of rapid bone loss and osteoporosis.

Authors:  T Naessén; I Persson; S Ljunghall; R Bergström
Journal:  Osteoporos Int       Date:  1992-09       Impact factor: 4.507

10.  [Factors influencing the adoption of hormone replacement therapy].

Authors:  F Légaré; S Dodin; G Godin
Journal:  Can Fam Physician       Date:  1998-06       Impact factor: 3.275

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.